Immunotherapy for renal cell carcinoma: The era of interleukin-2-based treatment

Samir S. Taneja, William Pierce, Robert Figlin, Arie Belldegrun

    Research output: Contribution to journalReview articlepeer-review

    Fingerprint

    Dive into the research topics of 'Immunotherapy for renal cell carcinoma: The era of interleukin-2-based treatment'. Together they form a unique fingerprint.